Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations
Abstract Parkinson’s disease (PD) is associated with both motor and non-motor symptoms, including constipation, sensory neuropathy, depression, dementia and sleep disorder. Somatostatin (SST) is considered to be a modulator of GABAergic inhibitory transmission, and its levels are reduced in cerebros...
Main Authors: | Chizuru Iwasawa, Naoko Kuzumaki, Yukari Suda, Reiko Kagawa, Yuko Oka, Nobutaka Hattori, Hideyuki Okano, Minoru Narita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13041-019-0426-7 |
Similar Items
-
Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology
by: Monika Liguz-Lecznar, et al.
Published: (2022-02-01) -
Complementary networks of cortical somatostatin interneurons enforce layer specific control
by: Alexander Naka, et al.
Published: (2019-03-01) -
NMDAR hypofunction and somatostatin-expressing GABAergic interneurons and receptors: A newly identified correlation and its effects in schizophrenia
by: Fatemah Alherz, et al.
Published: (2017-06-01) -
Astrocytes Modulate Somatostatin Interneuron Signaling in the Visual Cortex
by: Vanessa Jorge Henriques, et al.
Published: (2022-04-01) -
Somatostatin-expressing inhibitory interneurons in cortical circuits
by: Iryna Yavorska, et al.
Published: (2016-09-01)